HDAC11 and breast carcinoma: In addition, a KM plot analysis of breast cancer patients (n=500, HER negative) from GSE25066 (Hatzis et al., 2011) showed that patients with low HDAC11 expression had significantly shorter survival times than patients with high HDAC11 expression after chemotherapy (Figure 5—figure supplement 1E).